Clinical Trial Update: Preemptive Oral Gabapentin 600 mg in Reducing Morphine Requirement After Non Obstetric Lower Abdominal Surgery [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating preemptive oral gabapentin 600 mg to reduce morphine requirements after non-obstetric lower abdominal surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-obstetric Lower Abdominal Surgery

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

Sponsor: Indonesia University | Conditions: Non-obstetric Lower Abdominal Surgery | Phase 1, Phase 2 | Status: COMPLETED